Company attributes
Industry
Location
Full Address
10A, Prospekt 60-letiya Oktyabrya, Moscow, Russia 117036
3000 Sand Hill Rd, 2-240, Menlo Park, CA 94025
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
RUSNANO Capital is a joint stock company and state policy arm investing for the development of the nanoindustry in Russia. RUSNANO invests in Russia and the United States through RUSNANO USA, where they invest in and support global technology companies with an emphasis on nanotechnology.
Investment
RUSNANO Capital has made investments in OCSiAI Group, Pancela Labs, Selecta Biosciences, Motorica, Crocus Technology, KuibyshevAzot, Quantenna Communications, SiTime and Compass-EOS.
RUSNANO Capital has exited investments in Quantenna Communications, SiTime, Aquantia, Selecta Biosciences, Evofem Biosciences, NeoPhotonics, BIND Therapeutics, Regado Biosciences, Nesscap Energy and OptoGaN.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
